Sources sought, total small business set-aside
Real-World Application for Innovation and Development (RAPID)
FDA-SSN-75F40125Q00192
Food and Drug Administration, FDA Office of Acq Grant SVCS. Computer Systems Design Services.
Response deadline
May 27, 2025 at 12:00 PM EDT
Closed 479 days ago. Posted April 28, 2025. Scheduled to archive June 11, 2025.
Description
As published on SAM.gov.
The U.S. Food and Drug Administration (FDA) is issuing this source sought notice as a means of conducting market research, pursuant to FAR Part 10 Market Research, to identify viable industry parties capable of supporting FDA’s Real-World Application for Innovation and Development (RAPID), enhancement of the current AWS platform, development of new applications prototypes and Proof of Concepts.
The mission of CDER’s Office of Computational Science (OCS) is to modernize the Center’s regulatory review process and enable reviewers to spend less time dealing with complex data and more time applying their expertise to information through the use of integrated tools, services, and training. OCS’ efforts to accomplish this mission involve developing technology and analytics to support regulatory review work.
RAPID was developed as a means to implement a cloud-based and on-premises environment to develop and continuously improve the applications and databases needed to meet the innovation and analytical needs of FDA users.
The RAPID platform is capable of supporting a variety of cloud and other operations including, supporting individual regulatory research, ingest, evaluate, and validate new analytic tools and methodologies, support new methods of multi data base curation, characterization and integration for transdisciplinary analysis of complex and big data, and a range of artificial intelligence tools and use cases for FDA needs.
RAPID is a sandbox that promotes the development of innovative analytic tools, supports data science research, and the evaluation of cutting-edge technologies. The RAPID System in its current form uses Artificial Intelligence (AI) and cloud-based compute facilities to develop innovative analytical solutions that support regulatory decision making and scientific analysis.
Refer to the National Academies of Sciences “Convergence”, https://www.nae.edu/113283.aspx, report to get an understanding of what ”transdisciplinary FDA scientific need” must include.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
April 28, 2025
Sources sought
Due May 27, 2025 at 12:00 PM EDT. SAM.gov, notice 9b774fe5467f40f6b3aabd8b7601f752
Points of contact
- Noah PadillaNoah.Padilla@fda.hhs.gov
- Michelle Dacanaymichelle.dacanay@fda.hhs.gov
Also open from this buyer
- Animal BloodCombined synopsis and solicitationSmall businessNAICS 325414Silver Spring, MDCDRH2026134634Closes todaySep 18
- Rapid Nicotine Pouch Data Analysis ServicesCombined synopsis and solicitationNAICS 541618Silver Spring, MD75F40126Q00407Closes todaySep 18
- Vanquish Neo System and Ion Chromatography systemSolicitationNAICS 33451675F40126Q000430Closes in 3 daysSep 21
- Fourier Transform Infrared Spectrophotometer (FTIR)Combined synopsis and solicitationNAICS 334516San Juan, PR75F40126Q00406Closes in 4 daysSep 22
- 2D High-Density Multi-Electrode Array Electrophysiology PlatformCombined synopsis and solicitationNAICS 334516RFQ_CBER-2026-135968Closes in 5 daysSep 23